E. M. Molnar - Concepedia

Author

E. M. Molnar

Also Known As

E M Molnar, E MOLNAR, E Molnar, E Molnár, E. M. Molnar, E. Michael Molnar, E. Molnar, Emma Rozgonyiné Molnár, Eva Molnar, Molnar Eva

Publications

921

Citations

H-Index

Concepts

All Affiliations

Solvo Biotechnology (Hungary)University of Szeged University of Portsmouth Takeda (Japan)University of Debrecen

About

E. M. Molnar is an author at Solvo Biotechnology (Hungary) specializing in pharmacology, medicine, and biomedical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	99
2	Engineering	3	3	116
3	Biochemistry	3	3	97
4	Biomedical Engineering	3	3	116
5	Public Health	1	1	14

E. M. Molnar

Publications

580

Citations

H-Index

Page 1

	Year	Citations
Cholesterol Potentiates ABCG2 Activity in a Heterologous Expression System: Improved in Vitro Model to Study Function of Human ABCG2 Ákos Pál, Dóra Méhn, E. M. Molnar, Journal of Pharmacology and Experimental Therapeutics	2007	107
P-glycoprotein inhibition by membrane cholesterol modulation Ferenc Fenyvesi, Éva Fenyvesi, Lajos Szente, European Journal of Pharmaceutical Sciences Membrane Cholesterol ModulationOxysterolBiochemistryLipid MovementPharmacology	2008	73
Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance E. Kis, Tünde Nagy, Marghi Jani, Annals of the Rheumatic Diseases	2008	73
ABCG2 (Breast Cancer Resistance Protein/Mitoxantrone Resistance-Associated Protein) ATPase Assay: A Useful Tool to Detect Drug-Transporter Interactions Hristos Glavinas, Emese Kis, Ákos Pál, Drug Metabolism and Disposition	2007	71
Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation Petr Toman, Chun‐Fu Lien, Zeeshan Ahmad, Acta Biomaterialia NanoparticlesNanomedicineCell-based Drug DeliveryEngineeringTherapeutic Nanomaterials	2015	55
Characterization of 5(6)-Carboxy-2,′7′-Dichlorofluorescein Transport by MRP2 and Utilization of this Substrate as a Fluorescent Surrogate for LTC4 Krisztina Herédi‐Szabó, Emese Kis, E. M. Molnar, SLAS DISCOVERY	2008	43
In Vitro Assessment of Alkylglyceryl-Functionalized Chitosan Nanoparticles as Permeating Vectors for the Blood–Brain Barrier Chun‐Fu Lien, E. M. Molnar, Petr Toman, Biomacromolecules Tissue EngineeringNanoparticlesEngineeringBiofabricationVitro Assessment	2012	40
Kinetic Characterization of Sulfasalazine Transport by Human ATP-Binding Cassette G2 Márton Jani, Pál Szabó, Emese Kis, Biological and Pharmaceutical Bulletin	2009	37
Toward Drug Delivery into the Brain: Synthesis, Characterization, and Preliminary In Vitro Assessment of Alkylglyceryl-Functionalized Chitosan Nanoparticles E. M. Molnar, Eugen Barbu, Chun‐Fu Lien, Biomacromolecules NanoparticlesTissue EngineeringEngineeringVitro AssessmentBiomedical Engineering	2010	21
Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism Zoltán Mezei, Éva Katona, Judit Kállai, Thrombosis Research ThrombosisVenous ThrombosisCardiovascular DiseaseHematologyGenetic Epidemiology	2017	14

Page 1